Startups
NeuroVision Imaging
Sacramento, California, United States
NeuroVision Imaging, Inc. is a Sacramento healthcare technology company founded in2010, historically operating as NeuroVision Imaging LLC. Its current integrated platform combines BrainHealth Clinic telehealth cognitive care, Afina retinal imaging and Duritect blood-based biomarker development for neurodegenerative diseases. Afina is a cloud-based AI imaging pathway intended to identify retinal disease signatures and support treatment-safety monitoring; the company explicitly labels certain components investigational or under development and not FDA-cleared or approved. FDA records confirm Afina Release1.1 received510(k) clearance K181501 on November2,2018 for retinal-image importing, processing, display and autofluorescence measurement. The cleared software reports measurements for clinician interpretation and does not provide a specific clinical diagnosis; this does not establish clearance of an Alzheimer’s diagnostic claim or the company’s broader current biomarker platform. Research feasibility, clinical-service availability and device marketing authorisation are distinct. NeuroVision announced the acquisition of Durin Life Sciences on May12,2026, combining blood-biomarker programmes for Alzheimer’s, Parkinson’s and ALS with its retinal imaging and patient-care infrastructure; transaction consideration is undisclosed. CEO and co-founder Steven Verdooner continues to lead the combined company, and Durin majority owner Ric Edelman joined its board. Its current corporate website publishes seven directors; its own BrainHealth service publishes eleven operational leaders/staff and eight scientific advisers, with overlapping people reconciled. Historical scientific founders include Keith L. Black, Maya Koronyo-Hamaoui and Yosef Koronyo, associated with Cedars-Sinai retinal-amyloid research; their historical appointments are not assumed current executive jobs. A2016 Series B announcement confirms a USD5million lead investment from Wildcat Capital Management while reserving part of a USD10million financing for strategic investors. AMay2,2018 Series C completed an initial USD11.2million close toward USD15million; no additional USD15million cash event is inferred. Current primary investor materials also identify Labcorp, Gates Ventures, Tiny Orange Capital and Gaston Capital without round dates or allocations. The Alzheimer’s Drug Discovery Foundation reports two closed diagnostics projects awarded in2020 and2021; their funding instruments and payment timing require qualification.
Founded 2010
Team
 Annamarie RobinsonSR DIRECTOR OF FINANCE — BrainHealth/NeuroVision |
 Brian KnaussProduct Manager — BrainHealth/NeuroVision |
 Dawn LenakakisClinical Staff Manager — BrainHealth/NeuroVision |
 Douglas GalaskoScientific Advisory Board — BrainHealth |
 Eugeen VanmechelenScientific Advisory Board — BrainHealth |
 Gary RootDIRECTOR OF ENGINEERING — BrainHealth/NeuroVision |
 Glenn WalthallDirector |
 Greg ColeScientific Advisory Board — BrainHealth |
 Hamad RehmanSOFTWARE ENGINEER — BrainHealth/NeuroVision |
 Josef TamorySr Clinical Applications Specialist — BrainHealth/NeuroVision |
 Keith L. BlackCo-Founder; Chairman (historical, documented 2017–2018) |
 Larry WardScientific Advisory Board — BrainHealth |
 Leonard A. PotterDirector |
 Leyla AndersonVP Biomarker Development — BrainHealth/NeuroVision |
 Lynne HughesScientific Advisory Board — BrainHealth |
 Mark SelnaDirector · Scientific Advisory Board — BrainHealth |
 Maya Koronyo-HamaouiScientific Co-Founder and Inventor (historical documented appointment) |
 Mieko ChambersVP Operations — BrainHealth/NeuroVision |
 Miia KivipeltoScientific Advisory Board — BrainHealth |
 Rene ChazeDirector |
 Ric EdelmanDirector |
 Richard Travis WilkesChief Medical Officer — BrainHealth/NeuroVision |
 Roy TwymanDirector · Scientific Advisory Board — BrainHealth |
 Steven VerdoonerCEO, Director and Co-Founder |
 Traci ChuVP CRM — BrainHealth/NeuroVision |
Yosef KoronyoScientific Co-Founder and Inventor (historical documented appointment) |
